Detailansicht

Wissensnetz

Person

Mourad Sanhaji (1977-)

Biologe

Name	Mourad Sanhaji
Zeit	1977- (Lebensdaten)
Ort	Rabat (Geburtsort) Marokko
Beruf	Biologe (charakteristischer Beruf)
Variante	Mohamed Mourad Sanhaji
Weitere Angaben	Diss. Fachbereich Biowissenschaften, Univ. Frankfurt am Main
Datensatztyp	Person
GND-Nummer	143862855
Datensatz-ID	143862855
Beteiligt an alle anzeigen The Clinical Relevance of Fractional Curettage in the Diagnostic Management of Primary Endometrial Cancer Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1 Structure-based design of selective salt-inducible kinase (SIK) inhibitors The small-molecule inhibitor MRIA9 reveals novel insights into the cell cycle roles of SIK2 in ovarian cancer cells The prognostic relevance of the proliferation markers Ki-67 and Plk1 in early-stage ovarian cancer patients with serous, low-grade carcinoma based on mRNA and protein expression Blocking mitotic exit of ovarian cancer cells by pharmaceutical inhibition of the anaphase-promoting complex reduces chromosomal instability PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8 Polo-like kinase 1 regulates the stability of the mitotic centromere-associated kinesin in mitosis Funktionelle Regulation des Kinesins MCAK durch die Zellzyklus-Kinase Cyclin B1/CDK1 Mitotic centromere-associated kinesin (MCAK) : a potential cancer drug target Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells Funktionelle Regulation des Kinesins MCAK durch die Zellzyklus-Kinase Cyclin B1/CDK1

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Mourad Sanhaji (1977-)

The Clinical Relevance of Fractional Curettage in the Diagnostic Management of Primary Endometrial Cancer

Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer

The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer

A dimerization-dependent mechanism regulates enzymatic activation and nuclear entry of PLK1

Structure-based design of selective salt-inducible kinase (SIK) inhibitors

The small-molecule inhibitor MRIA9 reveals novel insights into the cell cycle roles of SIK2 in ovarian cancer cells

The prognostic relevance of the proliferation markers Ki-67 and Plk1 in early-stage ovarian cancer patients with serous, low-grade carcinoma based on mRNA and protein expression

Blocking mitotic exit of ovarian cancer cells by pharmaceutical inhibition of the anaphase-promoting complex reduces chromosomal instability

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells

Synthetic lethality in CCNE1-amplified high grade serous ovarian cancer through combined inhibition of Polo-like kinase 1 and microtubule dynamics

Ligand stimulation of CD95 induces activation of Plk3 followed by phosphorylation of caspase-8

Polo-like kinase 1 regulates the stability of the mitotic centromere-associated kinesin in mitosis

Funktionelle Regulation des Kinesins MCAK durch die Zellzyklus-Kinase Cyclin B1/CDK1

Mitotic centromere-associated kinesin (MCAK) : a potential cancer drug target

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells

Funktionelle Regulation des Kinesins MCAK durch die Zellzyklus-Kinase Cyclin B1/CDK1